Shares of Scienture Holdings, Inc. (SCNX) are moving up about 31 percent on Wednesday morning trading after the company formalized multiple commercial Group Purchasing Organization agreements for REZENOPYTM (naloxone HCl) Nasal Spray 10 mg.
The company's shares are currently trading at $0.51 on the Nasdaq, up 31.40 percent. The stock opened at $0.61 and has climbed as high as $0.64 so far in today's session. Over the past year, it has traded in a range of $0.37 to $3.17.
The agreements are expected to expand the company's institutional reach, providing access to more than 5000 healthcare facilities representing potential penetration into approximately 60% of the U.S. institutional market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.